col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


92 Results       Page 1

 [1] 
Elsevier: The Lancet Diabetes & Endocrinology
  original article Date Title Authors   All Authors
1 [GO] 2024―Jan―23 The impact of the COVID-19 pandemic and associated disruptions in health-care provision on clinical outcomes in people with diabetes: a systematic review Jamie Hartmann-Boyce, Patrick Highton, Karen Rees, Igho Onakpoya, Jana Suklan, Ffion Curtis, et al. (+8)
2 [GO] 2023―Oct―18 Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial O Abani, A Abbas, F Abbas, J Abbas, K Abbas, M Abbas, et al. (+7986)
3 [GO] 2023―Oct―18 Empagliflozin in adults hospitalised with COVID-19: a (null) hypothesis for RECOVERY Monia Garofolo, Giuseppe Penno
4 [GO] 2023―Apr―28 Effect of the COVID-19 pandemic on surgery for indeterminate thyroid nodules (THYCOVID): a retrospective, international, multicentre, cross-sectional study Fabio Medas, Chiara Dobrinja, Ebtesam Abdullah Al-Suhaimi, Julia Altmeier, Said Anajar, Akif Enes Arikan, et al. (+493)
5 [GO] 2023―Apr―28 Effect of COVID-19 restrictions on thyroid cytopathology: delay in the diagnosis of indeterminate lesions Esther Diana Rossi, Liron Pantanowitz
6 [GO] 2023―Mar―21 SARS-CoV-2 and type 1 diabetes in children in Finland: an observational study Mikael Knip, Anna Parviainen, Maaret Turtinen, Anna But, Taina Härkönen, Jussi Hepojoki, et al. (+7)
7 [GO] 2023―Jan―06 Blood lipids after COVID-19 infection Paul Durrington
8 [GO] 2022―Dec―02 Diabetes after SARS-CoV-2 infection Ziyad Al-Aly
9 [GO] 2022―Nov―07 The impact of the COVID-19 pandemic on diabetes services: planning for a global recovery Kamlesh Khunti, Vanita R Aroda, Pablo Aschner, Juliana C N Chan, Stefano Del Prato, Clare E Hambling, et al. (+6)
10 [GO] 2022―Oct―25 Out on a limb: living with diabetes in the Philippines during the pandemic Janine Patricia G Robredo, Diandra Lourdes D Cembrano
11 [GO] 2022―Oct―03 Impact of the COVID-19 pandemic on long-term trends in the prevalence of diabetic ketoacidosis at diagnosis of paediatric type 1 diabetes: an international multicentre study based on data from 13 national diabetes registries Niels H Birkebaek, Clemens Kamrath, Julia M Grimsmann, Karin Aakesson, Valentino Cherubini, Klemen Dovc, et al. (+20)
12 [GO] 2022―Oct―03 Rise in diabetic ketoacidosis during the COVID-19 pandemic: several questions remain Shivani Misra
13 [GO] 2022―Jul―01 Associations of BMI with COVID-19 vaccine uptake, vaccine effectiveness, and risk of severe COVID-19 outcomes after vaccination in England: a population-based cohort study Carmen Piernas, Martina Patone, Nerys M Astbury, Min Gao, Aziz Sheikh, Kamlesh Khunti, et al. (+6)
14 [GO] 2022―Jul―01 Impact of BMI on COVID-19 vaccine effectiveness Annelies Wilder-Smith, Annika Frahsa
15 [GO] 2022―Jun―09 Prioritising COVID-19 over everything: the unintended harm The Lancet Diabetes & Endocrinology
16 [GO] 2022―May―27 The effect of COVID-19 on routine diabetes care and mortality in people with diabetes David Hopkins, Francesco Rubino
17 [GO] 2022―May―27 Associations between reductions in routine care delivery and non-COVID-19-related mortality in people with diabetes in England during the COVID-19 pandemic: a population-based parallel cohort study Jonathan Valabhji, Emma Barron, Tessa Gorton, Chirag Bakhai, Partha Kar, Bob Young, et al. (+4)
18 [GO] 2022―Feb―03 Jennifer Manne-Goehler: at the crossroads of pandemics Ray Cavanaugh
19 [GO] 2022―Feb―01 Sexual dimorphism in COVID-19: potential clinical and public health implications Nicole Bechmann, Andreas Barthel, Andreas Schedl, Stephan Herzig, Zsuzsanna Varga, Catherine Gebhard, et al. (+13)
20 [GO] 2021―Dec―15 Dapagliflozin in patients with COVID-19: mind the kidneys Thiago Reis, Marlies Ostermann, Alexander Zarbock, John A Kellum, Claudio Ronco
21 [GO] 2021―Dec―15 Dapagliflozin in patients with COVID-19: mind the kidneys - Authors' reply Mikhail N Kosiborod, Russell Esterline, Jan Oscarsson, Samvel B Gasparyan, Remo H M Furtado, Subodh Verma, Otavio Berwanger
22 [GO] 2021―Dec―03 Childhood obesity: a growing pandemic The Lancet Diabetes & Endocrinology
23 [GO] 2021―Nov―29 COVID-19 and diabetes in Africa: a lethal combination Talha Burki
24 [GO] 2021―Nov―18 COVID-19 targets human adrenal glands Waldemar Kanczkowski, Katja Evert, Marlena Stadtmüller, Martina Haberecker, Laura Laks, Lan-Sun Chen, et al. (+9)
25 [GO] 2021―Oct―06 COVID-19 and metabolic disease: mechanisms and clinical management Charlotte Steenblock, Peter E H Schwarz, Barbara Ludwig, Andreas Linkermann, Paul Zimmet, Konstantin Kulebyakin, et al. (+30)
26 [GO] 2021―Sep―24 Impact of the COVID-19 pandemic on transgender and gender diverse health care Claire M Burgess, Abagail W Batchelder, Colleen A Sloan, Michael Ieong, Carl G Streed
27 [GO] 2021―Sep―02 Diabetic ketoacidosis risk during the COVID-19 pandemic Priyathama Vellanki, Guillermo E Umpierrez
28 [GO] 2021―Sep―02 Effect of the COVID-19 pandemic on body weight in people at high risk of type 2 diabetes referred to the English NHS Diabetes Prevention Programme Jonathan Valabhji, Emma Barron, Dominique Bradley, Chirag Bakhai, Kamlesh Khunti, Susan Jebb
29 [GO] 2021―Sep―02 Temporal trends in emergency admissions for diabetic ketoacidosis in people with diabetes in England before and during the COVID-19 pandemic: a population-based study Shivani Misra, Emma Barron, Eszter Vamos, Stephen Thomas, Ketan Dhatariya, Partha Kar, et al. (+3)
30 [GO] 2021―Jul―21 Dapagliflozin in patients with cardiometabolic risk factors hospitalised with COVID-19 (DARE-19): a randomised, double-blind, placebo-controlled, phase 3 trial Mikhail N Kosiborod, Russell Esterline, Remo H M Furtado, Jan Oscarsson, Samvel B Gasparyan, Gary G Koch, et al. (+29)
31 [GO] 2021―Jul―21 Dapagliflozin in patients with COVID-19: truth or dare Xavier Rossello, Francisca Caimari
32 [GO] 2021―May―12 Impact of COVID-19 on diagnoses, monitoring, and mortality in people with type 2 diabetes in the UK Matthew J Carr, Alison K Wright, Lalantha Leelarathna, Hood Thabit, Nicola Milne, Naresh Kanumilli, et al. (+2)
33 [GO] 2021―May―07 Food policies: in times of COVID-19 and beyond The Lancet Diabetes & Endocrinology
34 [GO] 2021―Apr―28 New insights into the association between body-mass index and severe COVID-19 Krishnan Bhaskaran
35 [GO] 2021―Apr―28 Associations between body-mass index and COVID-19 severity in 6·9 million people in England: a prospective, community-based, cohort study Min Gao, Carmen Piernas, Nerys M Astbury, Julia Hippisley-Cox, Stephen O'Rahilly, Paul Aveyard, Susan A Jebb
36 [GO] 2021―Apr―07 Distinguishing the real from the hyperglycaemia: does COVID-19 induce diabetes? Mark A Atkinson, Alvin C Powers
37 [GO] 2021―Mar―31 Can glucose-lowering drugs affect the prognosis of COVID-19 in patients with type 2 diabetes? Guntram Schernthaner
38 [GO] 2021―Mar―31 Prescription of glucose-lowering therapies and risk of COVID-19 mortality in people with type 2 diabetes: a nationwide observational study in England Kamlesh Khunti, Peter Knighton, Francesco Zaccardi, Chirag Bakhai, Emma Barron, Naomi Holman, et al. (+9)
39 [GO] 2021―Mar―18 Microvascular disease in diabetes and severe COVID-19 outcomes Antonella Corcillo, Martin B Whyte, Prashanth Vas, Janaka Karalliedde
40 [GO] 2021―Mar―18 Microvascular disease in diabetes and severe COVID-19 outcomes - Authors' reply Helen M Colhoun, Stuart J McGurnaghan, Paul M McKeigue
41 [GO] 2021―Feb―21 Risk and course of SARS-CoV-2 infection in patients treated for hypothyroidism and hyperthyroidism Thomas H Brix, Laszlo Hegedüs, Jesper Hallas, Lars C Lund
42 [GO] 2021―Feb―05 Avoiding a legacy of unequal non-communicable disease burden after the COVID-19 pandemic Nason Maani, Salma M Abdalla, Sandro Galea
43 [GO] 2021―Jan―19 COVID-19 vaccine prioritisation for type 1 and type 2 diabetes Alvin C Powers, David M Aronoff, Robert H Eckel
44 [GO] 2021―Jan―14 Vitamin D and COVID-19: why the controversy? The Lancet Diabetes & Endocrinology
45 [GO] 2021―Jan―10 Public health emergency or opportunity to profit? The two faces of the COVID-19 pandemic May CI van Schalkwyk, Nason Maani, Martin McKee
46 [GO] 2020―Dec―24 Risks of and risk factors for COVID-19 disease in people with diabetes: a cohort study of the total population of Scotland Stuart J McGurnaghan, Amanda Weir, Jen Bishop, Sharon Kennedy, Luke A K Blackbourn, David A McAllister, et al. (+62)
47 [GO] 2020―Dec―24 Observational research on severe COVID-19 in diabetes Coen D A Stehouwer
48 [GO] 2020―Dec―05 Coronavirus vaccine? Join the queue The Lancet Diabetes & Endocrinology
49 [GO] 2020―Nov―28 Global 30-day outcomes after bariatric surgery during the COVID-19 pandemic (GENEVA): an international cohort study Rishi Singhal, Abd A Tahrani, Christian Ludwig, Kamal Mahawar, A Abou-Mrad-Fricquegnon, A Alasfur, et al. (+234)
50 [GO] 2020―Oct―28 Catecholamine physiology and its implications in patients with COVID-19 Sriram Gubbi, Matthew A Nazari, David Taieb, Joanna Klubo-Gwiezdzinska, Karel Pacak
51 [GO] 2020―Oct―01 Diabetes, like COVID-19, is a wicked problem David Kerr, Namino Glantz
52 [GO] 2020―Sep―25 Tackling the COVID-19 pandemic in paradise: the Mauritian experience Sudhirsen Kowlessur, Bhushan Ori, Paul Zimmet, Jaakko Tuomilehto, Pierrot Chitson, Yogeshwaree Ramphul
53 [GO] 2020―Sep―15 Cortisol concentrations and mortality from COVID-19 Rimesh Pal, Mainak Banerjee, Sanjay K Bhadada
54 [GO] 2020―Sep―15 Cortisol concentrations and mortality from COVID-19 Kay W Choy
55 [GO] 2020―Sep―15 Cortisol concentrations and mortality from COVID-19 - Authors' reply Tricia Tan, Bernard Khoo, Edouard G Mills, Maria Phylactou, Bijal Patel, Pei C Eng, et al. (+7)
56 [GO] 2020―Sep―15 COVID-19 and diabetes: a co-conspiracy? The Lancet Diabetes & Endocrinology
57 [GO] 2020―Aug―18 Bariatric and metabolic surgery during and after the COVID-19 pandemic Melissa Santos, Eleanor Mackey, Bethany Gaffka, Wendy Ward, E Thomaseo Burton
58 [GO] 2020―Aug―18 Bariatric and metabolic surgery during and after the COVID-19 pandemic Bruno Halpern, Marcio C Mancini
59 [GO] 2020―Aug―18 Bariatric and metabolic surgery during and after the COVID-19 pandemic Vasileios Charalampakis, Basil J Ammori, Varadarajan Baskar, Martin Richardson, Rishi Singhal
60 [GO] 2020―Aug―18 Bariatric and metabolic surgery during and after the COVID-19 pandemic - Authors' reply David E Cummings, Francesco Rubino, Philip R Schauer, Ricardo V Cohen
61 [GO] 2020―Aug―13 Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study Emma Barron, Chirag Bakhai, Partha Kar, Andy Weaver, Dominique Bradley, Hassan Ismail, et al. (+7)
62 [GO] 2020―Aug―13 Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study Naomi Holman, Peter Knighton, Partha Kar, Jackie O'Keefe, Matt Curley, Andy Weaver, et al. (+7)
63 [GO] 2020―Aug―07 Obesity and COVID-19: Blame isn't a strategy The Lancet Diabetes & Endocrinology
64 [GO] 2020―Aug―03 Vitamin D for COVID-19: a case to answer? Adrian R Martineau, Nita G Forouhi
65 [GO] 2020―Jul―30 SARS-CoV-2-related atypical thyroiditis Ilaria Muller, Daniele Cannavaro, Davide Dazzi, Danila Covelli, Giovanna Mantovani, Antonio Muscatello, et al. (+13)
66 [GO] 2020―Jul―21 Management of diabetes in patients with COVID-19 Jagat J Mukherjee, Kalyan K Gangopadhyay, Subir Ray
67 [GO] 2020―Jul―21 Management of diabetes in patients with COVID-19 Jean-Daniel Lalau, Abdallah Al-Salameh
68 [GO] 2020―Jul―21 Management of diabetes in patients with COVID-19 Medha N Munshi, Sarah L Sy
69 [GO] 2020―Jul―21 Management of diabetes in patients with COVID-19 Mykola Khalangot
70 [GO] 2020―Jul―21 Back to normal? Building community resilience after COVID-19 Michael Penkler, Ruth Müller, Martha Kenney, Mark Hanson
71 [GO] 2020―Jul―21 Management of diabetes in patients with COVID-19 Adrian Li, Sophie Harris, Dulmini Kariyawasam, Dipesh C Patel, Stephen M Thomas
72 [GO] 2020―Jul―21 Management of diabetes in patients with COVID-19 - Authors' reply Stefan R Bornstein, Paul Zimmet, Francesco Rubino, Barbara Ludwig
73 [GO] 2020―Jul―21 Metabolic health and COVID-19: a call for greater medical nutrition education Juliet Burridge, James Bradfield, Ally Jaffee, Iain Broadley, Sumantra Ray
74 [GO] 2020―Jul―17 COVID-19 in people with diabetes: understanding the reasons for worse outcomes Matteo Apicella, Maria Cristina Campopiano, Michele Mantuano, Laura Mazoni, Alberto Coppelli, Stefano Del Prato
75 [GO] 2020―Jul―10 COVID-19 and Racism-a double edged dagger The Lancet Diabetes & Endocrinology
76 [GO] 2020―Jul―10 COVID-19 pandemic highlights racial health inequities Crystal Johnson-Mann, Monique Hassan, Shaneeta Johnson
77 [GO] 2020―Jul―09 Obesity and COVID-19: a call for action from people living with obesity S Le Brocq, K Clare, M Bryant, K Roberts, AA Tahrani
78 [GO] 2020―Jul―01 Protracted ketonaemia in hyperglycaemic emergencies in COVID-19: a retrospective case series Eleni Armeni, Umaira Aziz, Sulmaaz Qamar, Sadia Nasir, Chidambaram Nethaji, Rupert Negus, et al. (+8)
79 [GO] 2020―Jun―18 Association between high serum total cortisol concentrations and mortality from COVID-19 Tricia Tan, Bernard Khoo, Edouard G Mills, Maria Phylactou, Bijal Patel, Pei C Eng, et al. (+7)
80 [GO] 2020―Jun―09 COVID-19 and Cushing's syndrome: recommendations for a special population with endogenous glucocorticoid excess Rosario Pivonello, Rosario Ferrigno, Andrea M Isidori, Beverly M K Biller, Ashley B Grossman, Annamaria Colao
81 [GO] 2020―Jun―08 Technology in the COVID-19 era: pushing the boundaries The Lancet Diabetes & Endocrinology
82 [GO] 2020―May―21 Health care and mental health challenges for transgender individuals during the COVID-19 pandemic Yuanyuan Wang, Bailin Pan, Ye Liu, Amanda Wilson, Jianjun Ou, Runsen Chen
83 [GO] 2020―May―21 Vitamin-D and COVID-19: do deficient risk a poorer outcome? Fiona Mitchell
84 [GO] 2020―May―18 Prevalence of obesity among adult inpatients with COVID-19 in France Cyrielle Caussy, François Pattou, Florent Wallet, Chantal Simon, Sarah Chalopin, Charlène Telliam, et al. (+9)
85 [GO] 2020―May―16 How diabetes management is adapting amid the COVID-19 pandemic Peter Ranscombe
86 [GO] 2020―May―07 Bariatric and metabolic surgery during and after the COVID-19 pandemic: DSS recommendations for management of surgical candidates and postoperative patients and prioritisation of access to surgery Francesco Rubino, Ricardo V Cohen, Geltrude Mingrone, Carel W le Roux, Jeffrey I Mechanick, David E Arterburn, et al. (+17)
87 [GO] 2020―May―06 COVID-19: underlying metabolic health in the spotlight The Lancet Diabetes & Endocrinology
88 [GO] 2020―May―05 COVID-19, type 1 diabetes, and technology: why paediatric patients are leading the way Thomas Danne, Catarina Limbert
89 [GO] 2020―Apr―29 COVID-19 and obesity-lack of clarity, guidance, and implications for care Stuart William Flint, Abd A Tahrani
90 [GO] 2020―Apr―28 Managing diabetes in Qatar during the COVID-19 pandemic Shahrad Taheri, Odette Chagoury, Mary Tourette, Ioanna Skaroni, Manal Othman, Mohammed Bashir, et al. (+7)
91 [GO] 2020―Apr―23 Practical recommendations for the management of diabetes in patients with COVID-19 Stefan R Bornstein, Francesco Rubino, Kamlesh Khunti, Geltrude Mingrone, David Hopkins, Andreas L Birkenfeld, et al. (+14)
92 [GO] 2020―Apr―23 Use of glucocorticoids in patients with adrenal insufficiency and COVID-19 infection Andrea M Isidori, Riccardo Pofi, Valeria Hasenmajer, Andrea Lenzi, Rosario Pivonello
 [1] 

92 Results       Page 1



[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.017 sec